Moderna Inc. Stock Slides 7.8%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. slipped 7.8% to $218.01 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.1% to 26,140.03 and Dow Jones Industrial Average falling 0.3% to 52,002.41.

The stock's fall snapped a three-day winning streak.

Moderna Inc. closed 10.0% short of its 52-week high of $242.29, which the company achieved on October 15th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.9% to $255.56, Pfizer Inc. rose 0.5% to $29.58, and Gilead Sciences Inc. fell 0.75% to $156.19.

Trading volume totaled 21.3 million, compared to the 50-day average of 22.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 16, 2026 16:32 ET (20:32 GMT)